Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Mind Medicine (MindMed) Inc. - Common Shares (NQ:MNMD)

6.600 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mind Medicine (MindMed) Inc. - Common Shares

< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Psychedelic Stock Gainers And Losers From February 17, 2022
GAINERS: Mindset Pharma (OTC: 
Via Benzinga
Cybin, Deepak Chopra Announce Partnership For Psychedelics Awareness And Education
Psychedelics-focused biotech company Cybin Inc. (NYSE:CYBN) ... 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 15, 2022
GAINERS: Mind Medicine (NASDAQ: 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 14, 2022
GAINERS: Wellbeing Digital (OTC: 
Via Benzinga
Psychedelic And Cannabis Drug Stocks Continue Advance
This article updates the performances of 16 clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses. 
Via Talk Markets
Mind Medicine, Cybin Among Top Psychedelic Movers Of Today
GAINERS: Revive Therapeutics (OTC: RVVTF) shares closed up 2.51% at $0.22 LOSERS: Mind Medicine (NASDAQ: MNMD) shares closed down 8.09% at $1.25 Cybin (AMEX:CYBN) shares closed down 6.25% at $1.05 ATAI... 
Via Benzinga
Allied, Cybin Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC:ALID) shares closed up 7.39% at $1.89 
Via Benzinga
Psychedelic Stock Gainers And Losers From February 9, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 14.29% at $5.76 
Via Benzinga
Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th
The first Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking investors, is coming to the Fontainebleau Miami Beach on April 19, 2022,... 
Via Benzinga
Cathie Wood Is Buying this Peter Thiel-Backed Psychedelics Stock For Ark Funds
There’s a new psychedelics company being added to an ETF from Cathie Wood. What Happened: The Ark Genomic Revolution ETF (BATS: ARKG) took an initial position in shares of... 
Via Benzinga
Mindset Pharma, Cybin Among Top Psychedelic Movers Of Today
GAINERS: Awakn Life Sciences (OTC:AWKNF) shares closed up 3.51% at $1.62 
Via Benzinga
FDA Greenlight Sets the Stage for Upside With Mind Medicine
Few catalysts can move healthcare stocks like a regulatory clearance can -- and MNMD stock could be 2022's top psychedelics-sector investment. 
Via InvestorPlace
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 9.82% at $1.23 
Via Benzinga
Psychedelic Stocks Finally In An Upswing
The Marijuana & Psychedelic Compounds-Based Drug Stocks Index went up +5.3% last week. 
Via Talk Markets
Small Pharma, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 7.29% at $0.20 
Via Benzinga
Field Trip Health, Seelos Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 6.29% at $0.19 
Via Benzinga
Mind Medicine, Allied Among Top Psychedelic Movers Of Today
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 5.04% at $0.17 
Via Benzinga
New Psychedelics ETF Launches On NYSE Arca
Elemental Advisors Inc. has launched its first ETF, composed of companies involved in research, development, production or use of psychedelics to address medical conditions. The PSYK ETF (NYSE: PSYK)... 
Via Benzinga
Mindset Pharma, Allied Among Top Psychedelic Movers Of Today
GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 15.70% at $0.69 
Via Benzinga
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 7.89% at $5.33 
Via Benzinga
The Psychedelic & Marijuana Drug Stocks Index Dropped -30% In January
This article updates the performances of 16 clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses. 
Via Talk Markets
Psychedelic Stock Gainers And Losers From January 28, 2022
GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 17.86% at $0.57 
Via Benzinga
Bruce Linton's Óskare Capital Announces Strategic Cannabis Investment Partnership
Óskare Capital, the life science and deep tech fund owned by renown investor Bruce Linton and Alpha Blue Ocean, a global investment firm, announced on Thursday the formation of a strategic partnership... 
Via Benzinga
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today
GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 6.29% at $0.49 
Via Benzinga
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today
GAINERS: Small Pharma (OTC: 
Via Benzinga
MindMed Shares Soar After FDA Approves First Commercial Clinical Trial On LSD In 40 Years
MindMed (NASDAQ:MNMD), a drug development company in the p... 
Via Benzinga
51 Biggest Movers From Yesterday
Gainers Sierra Oncology, Inc. (NASDAQ: SRRA) shares climbed 46.2% to close at $22.68 on Tuesday after the company unveiled topline data for momelotinib in myelofibrosis patients... 
Via Benzinga
Mind Medicine, Mindset Pharma Among Top Psychedelic Movers Of Today
GAINERS: Mind Medicine (NASDAQ: 
Via Benzinga
BNTX Stock Alert: The Omicron Vaccine News That Has BioNTech Shooting Higher Today
BioNTech (BNTX) stock is rising higher on news it and Pfizer (PFE) can test a new Covid-19 vaccine for Omicron in adults. 
Via InvestorPlace
MNMD Stock: The FDA Go-Ahead That Has MindMed Investors Feeling Euphoric Today
MindMed (MNMD) stock is getting a buzz today thanks to approval from the FDA to move forward with a clinical trial of MM-120. 
Via InvestorPlace
< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.